CTSB and Alzheimer disease: The six different hAβPP models of AD used in CTSB KO studies differed in hAβPP isoforms, gene constructs, promoter driven expression for natural or abnormal expression of hAβPP isoforms in neurons compared to glia, and hAβPP containing Wt or Swe mutant β-secretase sites.